Ashkan Shoamanesh (@ash_shoamanesh) 's Twitter Profile
Ashkan Shoamanesh

@ash_shoamanesh

Stroke Neurologist @HamHealthSci
Associate Professor @McMasterU
Director of Hemorrhagic Stroke Research Program & Senior Scientist @PHRIresearch

ID: 1564301073392730112

linkhttps://experts.mcmaster.ca/display/shoamaa calendar_today29-08-2022 17:17:18

2,2K Tweet

1,1K Takipçi

448 Takip Edilen

JAMA Cardiology (@jamacardio) 's Twitter Profile Photo

In atrial fibrillation patients, those who were OAC naive had a smaller increase in stroke or systemic embolism and similar lower bleeding rates with asundexian compared to apixaban. ja.ma/444J7LN

In atrial fibrillation patients, those who were OAC naive had a smaller increase in stroke or systemic embolism and similar lower bleeding rates with asundexian compared to apixaban. ja.ma/444J7LN
International Journal of Stroke (@intjstroke) 's Twitter Profile Photo

📈Study finds herpes zoster infection to be associated with ⬆️stroke risk within 90 days post-infection 🧠Also a stronger risk factor for ICH journals.sagepub.com/doi/full/10.11…

📈Study finds herpes zoster infection to be associated with ⬆️stroke risk within 90 days post-infection

🧠Also a stronger risk factor for ICH

journals.sagepub.com/doi/full/10.11…
JAMA (@jama_current) 's Twitter Profile Photo

Authors, editors, reviewers, and other potential users should use CONSORT 2025 when writing and evaluating manuscripts of randomized trials to ensure that trial reports are clear and transparent. Learn more in this Special Communication. ja.ma/43ZDey9

Authors, editors, reviewers, and other potential users should use CONSORT 2025 when writing and evaluating manuscripts of randomized trials to ensure that trial reports are clear and transparent. 

Learn more in this Special Communication. ja.ma/43ZDey9
VJ Neurology (@vjneurology) 's Twitter Profile Photo

In an insightful interview, Diana Aguiar de Sousa of ULisboa shares highlights from clinical trials presented at #ESOC2025 and comments on the potential impact of their findings on patient care. Click to watch: 👉 ow.ly/accf50W8n8m #CTSM #NeuroTwitter #Stroke European Stroke Org

UCStrokeTeam (@ucstroketeam) 's Twitter Profile Photo

Please welcome us in congratulating our fellows for an outstanding year! Honored to welcome our newest colleagues, Dr Ian Yahnke, Dr Paul Wechsler, and Dr Lovisa Ljungberg!!! Eva A. Mistry, MBBS, MSCI, FAHA Paul Wechsler Ian Yahnke Stacie Christopher Richards Peyman Shirani, MD natalie kreitzer 🎓🧠🎊😊🥂

Please welcome us in congratulating our fellows for an outstanding year!  Honored to welcome our newest colleagues, Dr Ian Yahnke, Dr Paul Wechsler, and Dr Lovisa Ljungberg!!! <a href="/eva_mistry/">Eva A. Mistry, MBBS, MSCI, FAHA</a> <a href="/wechsler_paul/">Paul Wechsler</a> <a href="/iyahnke/">Ian Yahnke</a> <a href="/strokedoc79/">Stacie</a> <a href="/CTRMDMS/">Christopher Richards</a> <a href="/PeymanShirani/">Peyman Shirani, MD</a> <a href="/NatalieKreitzer/">natalie kreitzer</a> 🎓🧠🎊😊🥂
nancyatheart (@nancyatheart) 's Twitter Profile Photo

Renowned neurologist and epidemiologist, Dr. Mitch Elkind helped lead the American Heart Association through a global pandemic as 2020-21 president while revolutionizing the way we think about the heart-brain connection. For his transformational impact, Dr. Elkind is a recipient

Heart & Stroke (@heartandstroke) 's Twitter Profile Photo

"My vision is that no patient would be left with a diagnosis of stroke because of an unknown cause." Dr. nishita singh aims to revolutionize stroke causes and treatment. Watch and learn about the best outcome of Dr. Nishita Singh's research and read more. #StrokeMonth

CIHR (@cihr_irsc) 's Twitter Profile Photo

Congrats to the 6 newest members inducted into the Canadian Medical Hall Fame, including a former CIHR Governing Council member, CIHR funding recipients and award winners, and the first woman licensed to practise medicine in Canada. cdnmedhall.ca/induction?hsid…

Congrats to the 6 newest members inducted into the <a href="/CdnMedHallFame/">Canadian Medical Hall Fame</a>, including a former CIHR Governing Council member, CIHR funding recipients and award winners, and the first woman licensed to practise medicine in Canada.
 
cdnmedhall.ca/induction?hsid…
VJ Neurology (@vjneurology) 's Twitter Profile Photo

Want an insight into the CERES-TANDEM study, which investigated the use of emergent carotid stenting during thrombectomy in patients with anterior circulation tandem lesion #stroke? Then watch our recent interview with Michele Romoli here: 👉 ow.ly/JVbg50W8nNy #ESOC2025

David Seiffge (@davidseiffge) 's Twitter Profile Photo

News from the Swiss Stroke Registry by ⁦Martina Göldlin: DWI-lesions in ICH are frequent, already on admission before any intervention; associationbwith CAA and SVD burden. Suitable surrogate outcome in trials?Stroke Research Center Bern⁩ ⁦Neurology Journal⁩ neurology.org/doi/10.1212/WN…

Ashkan Shoamanesh (@ash_shoamanesh) 's Twitter Profile Photo

Direct comparison of apixaban with rivaroxaban for treatment of VTE shows excess bleeding with rivaroxaban in the COBRA randomized trial.

JAMA Neurology (@jamaneuro) 's Twitter Profile Photo

APOE epsilon ε4 is a significant risk factor for intracranial hemorrhage in patients with atrial fibrillation on apixaban. ja.ma/442CjwX Kevin Sheth Thomas Gill

APOE epsilon ε4 is a significant risk factor for intracranial hemorrhage in patients with atrial fibrillation on apixaban. ja.ma/442CjwX <a href="/sheth_kevin/">Kevin Sheth</a> <a href="/MrDisability/">Thomas Gill</a>
World Stroke Academy (@worldstrokeed) 's Twitter Profile Photo

#MondayTip 📊Pooled INTERACT data ✅Intensive BP lowering improves recovery in ICH ⏱️When started <3h (cutoff: 2.6h)➡️reduces haematoma growth ☝️Greatest benefit in mild–moderate ICH (ICH score) 🚨Early treatment improves outcomes👉supports CODE-ICH systems & future trial design

#MondayTip
📊Pooled INTERACT data

✅Intensive BP lowering improves recovery in ICH
⏱️When started &lt;3h (cutoff: 2.6h)➡️reduces haematoma growth
☝️Greatest benefit in mild–moderate ICH (ICH score)
🚨Early treatment improves outcomes👉supports CODE-ICH systems &amp; future trial design
Liverpool Centre for Cardiovascular Science (@liverpoolccs) 's Twitter Profile Photo

Collaboration on the optimal timing of anticoagulation after ischaemic #stroke and atrial fibrillation #Afib: systematic review and prospective individual participant data meta-analysis of RCTs (CATALYST)LHCH Liverpool Health Partners LJMUHealth sciencedirect.com/science/articl…

Collaboration on the optimal timing of anticoagulation after ischaemic #stroke and atrial fibrillation #Afib: systematic review and prospective individual participant data meta-analysis of RCTs (CATALYST)<a href="/LHCHFT/">LHCH</a> <a href="/LivHPartners/">Liverpool Health Partners</a> <a href="/LJMU_Health/">LJMUHealth</a>  sciencedirect.com/science/articl…